Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors by Ritchie, K et al.
RESEARCH
Designing prevention programmes to reduce incidence of
dementia: prospective cohort study of modifiable risk
factors
KRitchie,seniorresearchdirector,
1,2,3ICarrie `re,researchfellow,
1,2CWRitchie,consultantpsychiatrist,
3CBerr,
research director,
1,2 S Artero, research fellow,
1,2 M-L Ancelin, research director
1,2
ABSTRACT
Objective To estimate the percentage reduction in
incidence of dementia that would be obtained if specific
risk factors were eliminated.
Design Prospective seven year cohort study.
Setting General population, Montpellier, France.
Participants 1433 people aged over 65 with a mean
baseline age of 72.5 (SD 5.1) years.
Main outcome measures Diagnosis of mild cognitive
impairment or dementia established by a standardised
neurological examination.
Results Cox models were constructed to derive hazard
ratios and determine confounding and interaction effects
for potentially modifiable risk factors for dementia. Mean
percentage population attributable fractions were
calculated with 95% confidence intervals derived from
bootstrapping for seven year incidence of mild cognitive
impairment or dementia. The final model retained
crystallised intelligence (population attributable fraction
18.11%, 95% confidence interval 10.91% to 25.42%),
depression (10.31%, 3.66% to 17.17%), fruit and
vegetable consumption (6.46%, 0.15% to 13.06%),
diabetes (4.88%, 1.87% to 7.98%), and apolipoprotein E
ε4 allele (7.11%, 2.44% to 11.98%).
Conclusions Increasing crystallised intelligence and fruit
and vegetable consumption and eliminating depression
and diabetes are likely to have the biggest impact on
reducingtheincidenceofdementia,outweighingeventhe
effect of removing the principal known geneticrisk factor.
Although causal relations cannot be concluded with
certainty, the study suggests priorities that may inform
public health programmes.
INTRODUCTION
The past 30 years have seen the proliferation of meth-
odologically well constructed prospective population
studies of dementia that have pointed to multiple risk
factors. Although the exact cause of the dementias
remains unknown, these studies together suggest a
complex interaction of exposures that contribute dif-
ferentiallytothe probability andtimingofonsetofdis-
ease. The contribution of epidemiology to dementia
research has, however, been principally in the areas
of observational and analytical epidemiology—that
is, the establishment of incidence and prevalence
rates and demonstration of interactive risk factors
used to inform clinical research and drug treatment.
On the other hand, interventional epidemiology—
that is, the designation of intervention points at the
levelofthepopulationforthereductionofdiseaseinci-
dence—hasbeenrelativelyneglected.Historically,this
has been an important function of epidemiological
research; public health strategies based on risk
removal have previously reduced disease incidence
even when the exact cause of the disease was still
unknown—for example, hand washing to prevent
puerperal fever, controlling water sources to prevent
cholera,andrecommendingtheuseofcondomstopre-
vent the spread of AIDS.
Clinical and biological research into the dementias
hadmadeconsiderableprogresstowardstheendofthe
20th century, leading to the marketing of treatments
for the symptoms of dementia that will most likely,
however, have the effect of increasing the prevalence
of disease by extending its duration without having an
impact on incidence. In the face of a pandemic of
dementia, with predicted increases of 100% in devel-
opedcountriesbetween2001and2020,andof300%in
China, India, and neighbouring south Asian and wes-
tern Pacific countries,
1 even small reductions in inci-
dence, or delaying the age of onset, are likely to have
significant effects on prevalence and the enormous
associated public health burden. The application of a
general population approach to prevention of demen-
tiabasedontheprinciplesofinterventionalepidemiol-
ogy, and targeting risk factors likely to decrease
incidence in the absence of a coherent aetiological
model, thus seems timely.
This study firstly identifiedcandidate risk factors for
dementia that have already been identified by popula-
tion studies using internationally recognised algo-
rithms for dementia, and which may potentially be
the focus of intervention strategies. The second step
wastoexaminewithina prospective cohorttheimpact
on incidence of the theoretical elimination of each of
these risk factors, taking into account the other factors.
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current epidemiological knowledge, which inter-
ventions at a population level might be most efficient
inreducingtheburdenofdementiainthecomingyears
if no effective treatment is found.
METHODS
Candidate exposures
We identified potentially modifiable risk factors for
dementia from population and clinical studies cited in
PubMed since 1980 (this date coincides with the pub-
licationofinternationallyacceptedresearchguidelines
for diagnosis of dementia). These candidate inter-
vention factors may broadly be divided into socio-
demographic, clinical, and environmental and lifestyle
factors.
Sociodemographic factors—Age is the most important
risk factor for dementia; the incidence rises exponen-
tially between the ages of 60 and 80, and the rate of
increase slows thereafter.
2-4 Although theoretically
non-modifiable, this is a principal confounding factor
thatmustbetakenintoaccount.Educationseemstobe
an important protective factor; evidence indicates that
this may be due to compensation in higher age groups
(neuronal reserve), which delays the onset of clinical
signs.
5 Ethnic differences consist of both non-modifi-
able (genetic) and modifiable (cultural) components.
Most ethnic differences in risk for dementia that have
been identified are due to methodological differences,
withtheexceptionofastudyofAfricansinNigeriaand
the United States, in which the second group were
foundtohaveahigherincidenceofdementia,
6suggest-
ing a modifiable component.
Clinical factors—Risk for late onset Alzheimer’s dis-
ease is known to be associated with polymorphisms of
the apolipoprotein E (ApoE) gene; people with an ε4
allelehaveanincreasedriskofbothfamilialandspora-
dic forms, accounting for 20-50% of the attributable
risk.
78 Although this is currently a non-modifiable
risk factor, we cite it here because of its potential for
modifying the impact of other factors, implying that
some interventions may perhaps best be restricted to
people at genetic risk. With regard to past health
events, head injury has been found to double the risk
for Alzheimer’s disease in men,
9 with increased risk in
those with an ApoE ε4 allele.
10 Established vascular
risk factors (heart disease, stroke, hypertension, obe-
sity, diabetes, and elevated plasma homocysteine and
cholesterol concentrations) increase the risk for both
vascular dementia and Alzheimer’s disease and accel-
erate the associated cognitive decline.
11-16 A history of
depression, asthma, and repeated exposure to herpes
simplex type I virus in the presence of an ApoE ε4
allele have also been observed to increase the risk of
dementia.
17-19 With regard to treatments, the use of
non-steroidal anti-inflammatory agents and hormonal
replacement therapy in menopausal women has been
found by most studies to reduce the risk for dementia
and also to diminish the risk effect of ApoE ε4,
20-22
whereas exposure to anaesthesia and use of drugs
with anticholinergic effects have been shown to
increase risk.
23-25
Environmental and lifestyle factors—Participation in
cognitively stimulating activities and an active and
socially integrated lifestyle have both been observed
to delay the onset of dementia.
26-28 A Mediterranean-
typedietwithhighconsumptionofvegetablesand fish
(n-3 polyunsaturated fatty acids) has been observed to
reduce the risk of incident Alzheimer’s disease.
2930
Moderate consumption of alcohol has been observed
to be a protective factor in non-ApoE ε4 carriers,
3132
whereas heavy drinking may lower the age of onset of
Alzheimer’sdisease.
33 Caffeineconsumptionhas been
associated with a reduction in density of white matter
lesions and possible delaying of onset of dementia,
34
and inadequate consumption of water has been
observed to increase risk.
35 Nicotine intake has also
been observed to decrease the risk of dementia,
36
although more recent studies have suggested that it
may increase it and also bring forward age of onset
with an ApoE ε4 interactive effect.
37
Not all of the above risk factors have been consis-
tently confirmed by subsequent studies, and consider-
able inconsistencies exist between observations as a
resultofmethodologicaldifferences.Wedonotintend
the above summary to critically review these studies,
however, but rather to generate a list of candidate risk
factors for which strong empirical evidence already
exists and which are modifiable, for use in modelling
theeffectsofinterventions.Theriskfactorsconsidered
here are those that may potentially be avoided or
reversed, with the exception of ApoE ε4 genotype,
which we have retained as a benchmark for compari-
son purposes given its strong and consistent associa-
tion with dementia and cognitive decline. We
included age and sex as adjustment variables.
Participants
The Esprit Study is a neuropsychiatric cohort study of
community dwelling people aged 65 years and over
drawn at random from the electoral rolls of Montpel-
lier in the south of France and recruited between 1999
and2001.Participantshavebeenreassessedatbaseline
and at two, four, and seven years. Each participant
gave written informed consent.
Procedures
Aneurologistexaminedallparticipantsatbaselineand
at two, four, and seven year follow-up by using a
standardised interview incorporating cognitive testing
to identify both dementia and mild cognitive
impairment.
38 Mild cognitive impairment is consid-
ered to be a prodrome of dementia; we have included
it here to cover cases of slowly evolving dementia that
may be diagnosed after the seven year follow-up. We
havepreviouslyshownthattheapplicationofthemod-
ified Peterson’s criteria for mild cognitive impairment
in this population identifies people with cognitive dif-
ficultieswitha veryhighlikelihoodoflaterdeveloping
dementia.
38 These participants cannot be considered
not to have dementia, and their removal would risk
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a public health intervention should target both diag-
nosed and prodromal dementia, and we included inci-
dentcasesofmildcognitiveimpairmentwithdementia
inouranalyses.Wedefinedpeoplewithmildcognitive
impairment as those with a score (on at least one cog-
nitive test) in the lowest baseline fifth in relation to the
relevant age matched and education matched group
and with a cognitive complaint. We used fifths rather
than standard deviations, as in other studies in which
the cognitive scores are not normally distributed. A
panel of expert neurologists further validated all inci-
dent cases of dementia and mild cognitive impairment
independently from the study investigators. We con-
sideredthe date of onsetof dementia or mild cognitive
impairmenttobethedate ofthe follow-upinterviewat
which dementia or mild cognitive impairment was
diagnosed.
Astandardisedinterviewby trainednursesincluded
questions on sociodemographic characteristics and
educationallevel(classifiedinfourgroupscorrespond-
ing to 5, 9, 12, and ≥12 years of education). The Neale
adult reading test is a measure of IQ that is based on
degree of exposure to, and integration of, culture spe-
cific information and is usually not modified in early
stagedementia.
39Itmaybeconsideredtobeameasure
of crystallised intelligence. We chose the threshold for
thereadingtestscore(<20correspondingtolowerper-
formance) in view of the non-linear risk curve (test of
non-linearity, P=0.008). We used this measure as a
proxy for lifelong cognitive activity as a complement
to years of education, which covers principally child-
hood. We also obtained information relating to
monthly income, mobility and confinement to home
and neighbourhood, height, and weight. We used
nutritional questionnaires to obtain information on
consumption of fruit and vegetables (two portions a
day versus less) and fish (once a week versus less). We
obtained information on type and quantity of alcohol
consumption (>36 g/day in men and >24 g/day in
women versus less) and tobacco use (classified as
past/present or never users), daily water consumption
(less than 1 l/day versus ≥1 l/day), and coffee and tea
intake (≤3 cups/day versus more, assuming one cup of
coffee to be equal to two cups of tea).
We established history of exposure to anaesthesia
over two years; repeated herpes infections; asthma;
and lifetime history of hypertension, hypercholestero-
laemia, stroke, and ischaemic heart disease (angina
pectoris, myocardial infarction, cardiac and vascular
surgery) according to standardised questions with
additional information where necessary from general
practitioners. For people who reported the occurrence
of vascular events during follow-up, we obtained con-
firmation from general practitioners, specialists, and
hospitalrecords.Theinterviewalsoincludedaninven-
toryofalldrugsusedduringtheprecedingmonth,not-
ing those with potential anticholinergic effects,
2425 and
past and present versus never users of hormone repla-
cement therapy. The interviewer saw medical pre-
scriptions and, where feasible, the drugs themselves.
WeassesseddepressivesymptomsbyusingtheCenter
for Epidemiological Studies depression scale with a
threshold of 16 points,
40 and we diagnosed current
major depressive episodes with the MINI neuropsy-
chiatric examination.
41 We considered participants
identified by either method or taking antidepressants
tobecasesofdepression.Wemeasuredbloodpressure
twice during the interview by using a digital electronic
tensiometer OMRON M4, with hypertension defined
as the mean of the two measures being ≥140/90 mm
Hgortreatmentforhypertensionandhighpulserateas
≥80 bpm. We took fasting blood samples for ApoE
ε4 genotyping and assessment of hypercholesterolae-
mia(hightotalcholesterol≥7.25 mmol/loruse ofcho-
lesterol lowering agents) and diabetes (defined as
glycaemia ≥7 mmol/l or antidiabetic treatment). We
dichotomised body mass index (weight in kilograms
divided by the square of height in metres) as lower
than 20.5 versus 20.5 or above. We defined baseline
metabolicsyndromeaccordingtotheNationalCholes-
terol Education Program Adult Treatment Panel III
criteria, which require the presence of three or more
alterationsamongthe followingcardiometabolicpara-
meters: high systolic (>130 mm Hg) or diastolic blood
pressure (>85 mm Hg) or use of antihypertensive
drugs; large waist circumference (>88 cm in women
and >102 cm in men); high triglycerides (≥1.7 mmol/
l);lowhighdensitylipoproteincholesterol(men<1.04
andwomen<1.29mmol/l);andhighfastingglycaemia
(≥6.1 mmol/l) or antidiabetes drugs.
42
Although the type of dementia was differentiated in
the clinical interview, we have chosen to group
togetheralldementiasandmildcognitiveimpairment.
Differentiation may be preferable in an analytical
study attempting to clarify causation, but in this con-
texttheprincipaloutcomewillbeapublichealthinter-
vention at a population level, which we assume would
preferably target all dementia and its prodrome state.
Moreover, most of the risk factors examined are com-
mon to the different forms of dementia.
Statistical methods
We used a prospective general population database
(the Esprit Study) to examine the individual impact of
each of these risk factors and protective factors on the
incidenceofdementiabycalculatinghazardratios.We
used a Cox model with delayed entry in the longitudi-
nal analysis of incident cases of mild cognitive impair-
mentordementiaoverthesevenyearfollow-up,taking
age as the basic timescale and birth as the time origin.
We censored participants who died without dementia
or mild cognitive impairment at their age of death and
those who were lost to follow-up before developing
dementia or mild cognitive impairment at the last cog-
nitive examination. The age of onset of the event
(dementia or mild cognitive impairment) was the mid-
dle of the interval between the last follow-up without
the event and the first follow-up with the event. The
risk factors found to be significant (P<0.15) in a uni-
variate model (adjusted for sex) were included in the
multivariate model, which was reduced with a
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the statistical analyses.
Given that many of the exposures discussed above
are likely to be relatively rare, so intervention at a gen-
eral population level may not be cost effective, the
population attributable fraction is a better index of
the potential for prevention through general popula-
tion intervention than is attributable risk. The popula-
tion attributable fraction takes into account both the
relative risk and the frequency of the risk factor; it esti-
mates the proportion of incident cases in the general
population that would be prevented if the exposure
was entirely eliminated. The population attributable
fraction theoretically estimates the reduction in inci-
dence of disease that would be obtained if the entire
population was not exposed to a given risk, compared
with current rates of exposure. However, as the calcu-
lations are based on incidences, a time of reference
must be taken into account (incidence over a given
numberofyears)
43;furthermore,inthecaseofdiseases
such as dementia with multifactorial aetiology, com-
peting risk factors must also be simultaneouslyconsid-
ered.Thedefinitionofpopulationattributablefraction
usedhereisthusthemeanproportioninriskreduction
over seven years that would be obtained if a specific
exposure was entirely eliminated from the population
while the distribution of other risk factors remains
unchanged.
44
Estimation of population attributable fraction
requires categorical covariates (preferably binary to
avoid ambiguity in interpretation), so a threshold
must be selected that is both clinically meaningful
andpragmaticasapotentialpublichealthintervention.
As with any multivariate model, problems of colinear-
ityarisefromthesimultaneoususeofhighlycorrelated
variables. Interaction effects also need to be tested to
determinewhetherresultscanbepooled.Inthecaseof
dementia, we need to consider, for example, whether
separate calculations should be made for men and
women or for people with and without an ApoE ε4
allele; the corollary is that specific intervention pro-
grammes should then be developed for these sub-
groups.
We initially included all of the risk factors described
aboveinouranalyses(withtheexceptionofageandsex,
which are considered non-modifiable and appear as
adjustment variables, and ethnicity, which could not
be included in this French study for ethical reasons).
CovariateshavebeenselectedbyCoxmodelsincluding
allriskandconfoundingfactors.Themodelisalsoused
to test interaction effects. The formula most commonly
cited for the calculation of population attributable frac-
tion is PAF=IRtotal exposed and non-exposed−IRnon-exposed/
IRtotal exposed and non-exposed, where IR=incidence risk.
However,thismodelisnotappropriateinthecaseof
the dementias, for which interaction and confounding
across variables are likely. We have thus used a for-
mula based on the adjusted relative risks (RRadj)
derived from a multivariate model: PAF={(RRadj−1)/
RRadj}P e(cases), where Pe(cases) is the prevalence of the
exposureinparticipantswithdementia.Wecalculated
the relative risk with a Cox model yielding hazard
ratios. The confidence intervals for the population
attributable fraction are estimated by the bootstrap
re-sampling method. In our analysis, we generated
1000 samples from the original dataset, calculated the
population attributable fractions for each sample, and
calculated the 95% confidence interval.
RESULTS
For our analyses, we used data from the 1433 people
withoutadiagnosisofeithermildcognitiveimpairment
or dementia at baseline, for whom cognitive status was
assessedduringfollow-upanddatawereavailableonall
risk factors for the final model (figure). The baseline
mean age of the population was 72.5 (SD 5.1) years.
The median length of follow-up was 7.31 (interquartile
range 2.72-7.58) years, and 405 incident cases of all
cause dementia and mild cognitive impairment were
validated. Table 1 shows the baseline sociodemo-
graphic and clinical characteristics of participants,
alongwithanon-adjustedχ
2comparisonofparticipants
whodevelopedmildcognitiveimpairmentordementia
over the next seven years with those who did not for
each of the potential risk factors. We found no differ-
ence between men and women in rates of incident
mild cognitive impairment or dementia.
We examined the association between each of these
candidate risk factors and incidence of mild cognitive
impairment or dementia at two, four, or seven year
follow-up by univariate analyses adjusted for age and
sex. Results showed significant associations of inci-
dence with low education and Neale adult reading
test score, depression,stroke, diabetes, ApoE ε4 allele,
ischaemic heart disease, head injury, caffeine con-
sumption,exposureto anaesthesia,and fruitand vege-
table consumption. We found no interaction effects
with sex and ApoE ε4 allele, except an interaction
between sex and depression (P=0.03; depressed
ESPRIT cohort (n=2259)
Included (n=1770)
Without cognitive evaluation for follow-up (n=160)
Excluded (n=489):
  Dementia (n=70)
  Mild cognitive impairment (n=324)
  No cognitive evaluation (n=95)
Followed up (n=1610)
Final sample (n=1433)
Information missing for at least one risk factor (n=177)
Censored
owing to
death (n=85)
Censored
and alive
(n=943)
Mild
cognitive
impairment
(n=374)
Dementia
(n=31)
Flow diagram
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therefore not stratified.
We constructed a global stepwise descending Cox
model from risk factors in the previous analysis. We
took age as the basic timescale and birth as the time
originina delayedentrymodel(table 2). Weincluded
all the covariates found to be significant in the preced-
ing step at a level of P<0.15. This multivariate model
wasreducedby usinga backwardmethodwitha prob-
ability of staying in the model of P<0.05. The final
model provides mean population attributable fraction
estimations. We used multiple sampling (bootstrap-
ping) to estimate 95% confidence intervals. Crystal-
lised intelligence (Neale adult reading test score),
diabetes, ApoE4, fruit and vegetable consumption,
and depression were retained in the final model. As
Neale adult reading test scores and mild cognitive
impairment are both indicators of poor cognitive per-
formance,andthefirstislikelytobeariskfactorforthe
second, we examined the risk of high and low reading
test scores with incident dementia only as an outcome
within a Cox model. This independent association
remainsstrong(hazardratio2.9,95%confidenceinter-
val 1.6 to 5.2; P<0.0005).
DISCUSSION
We constructed Cox models to derive hazard ratios
and determine confounding and interaction effects
for potentially modifiable risk factors for dementia
and calculated mean percentage population attributa-
blefractionsforsevenyearincidenceofmildcognitive
impairment or dementia. The final model retained
crystallised intelligence, depression, fruit and vegeta-
ble consumption, diabetes, and apolipoprotein E ε4
allele.
Relative impact of different risk factors
Estimations of population attributable fraction suggest
that elimination of the ApoE ε4 allele from the general
population would lead only to a 7.1% reduction in the
number of incident cases of mild cognitive impairment
or dementia over the next seven years. Genetic modifi-
cation is clearly not a feasible goal for public health
intervention,butasitconstitutesoneofthemostsignifi-
cant risk factors for dementia we have taken it as a
benchmark for the comparison of other exposures.
The greatest impact in terms of prevention is estimated
tocomefromincreasingNealeadultreadingtestscores,
leading to an 18.1% reduction in incidence of mild
Table 1 |Baseline characteristics of participants and sex and age adjusted hazard ratio for seven year incident mild cognitive
impairment (MCI) or dementia (n=1433). Values are numbers (percentages) unless stated otherwise
Characteristic
No dementia or MCI during
follow-up (n=1028)
Dementia or MCI during
follow-up (n=405)
χ2 test P
value
Cox model
Hazard ratio (95% CI) P value
Female 621 (60.4) 241 (59.5) 0.75
Age (years):
65-69 397 (38.6) 85 (21.0)
<0.001
70-74 358 (34.8) 138 (34.1)
75-80 194 (18.9) 117 (28.9)
≥80 79 (7.7) 65 (16.1)
Education ≤5years 214 (20.8) 98 (24.2) 0.16 1.27 (1.01 to 1.59) 0.04
Neale adult reading test <20 311 (30.3) 176 (43.5) <0.001 1.74 (1.43 to 2.12) <0.001
Body mass index <20.5 87/1022 (8.5) 31/401 (7.7) 0.63 0.82 (0.56 to 1.19) 0.28
Diabetes 57 (5.5) 43 (10.6) <0.001 1.93 (1.40 to 2.66) <0.001
Fish <once/week 117/1027 (11.4) 50/405 (12.4) 0.61 1.13 (0.84 to 1.52) 0.43
Fruit/vegetables <twice/day 256 (24.9) 127 (31.4) 0.01 1.38 (1.11 to 1.70) 0.003
Depression 290 (28.2) 149 (36.8) 0.002 1.48 (1.20 to 1.82) <0.001
Hypertension 571/967 (59.1) 220/370 (59.5) 0.89 0.96 (0.78 to 1.19) 0.72
Hypercholesterolaemia 352/1027 (34.3) 139/405 (34.3) 0.99 1.06 (0.86 to 1.30) 0.61
Anticholinergic drugs 42 (4.1) 23 (5.7) 0.19 1.41 (0.92 to 2.15) 0.11
Ischaemic heart disease 91 (8.9) 50 (12.3) 0.05 1.39 (1.03 to 1.89) 0.03
Stroke 21/1020 (2.1) 15/401 (3.7) 0.07 1.96 (1.16 to 3.29) 0.01
Head injury 79/1018 (7.8) 37/400 (9.3) 0.36 1.46 (1.03 to 2.05) 0.03
Asthma 20/1022 (2.0) 3/400 (0.8) 0.10 0.42 (0.13 to 1.30) 0.13
Metabolic syndrome 132/1027 (12.9) 53/405 (13.1) 0.91 1.10 (0.82 to 1.47) 0.52
Herpes 375/1022 (36.7) 156/402 (38.8) 0.46 1.11 (0.91 to 1.35) 0.32
Living alone 270/1025 (26.3) 119/405 (29.4) 0.24 1.00 (0.79 to 1.27) 0.99
Caffeine ≤3 cups/day 792 (77.0) 338 (83.5) 0.007 1.37 (1.05 to 1.78) 0.02
Alcohol 121/1006 (12.0) 45/399 (11.3) 0.69 0.99 (0.72 to 1.37) 0.97
Current smoking 63/1027 (6.1) 22/405 (5.4) 0.61 0.97 (0.63 to 1.49) 0.88
Water <1 l/day 277/1027 (27.0) 104/405 (25.7) 0.62 0.91 (0.73 to 1.13) 0.39
Pulse rate ≥80 bpm 200/957 (20.9) 62/369 (16.8) 0.09 0.81 (0.61 to 1.06) 0.13
ApoE4 ε4 allele 181 (17.6) 90 (22.2) 0.04 1.41 (1.11 to 1.78) 0.005
Anaesthesia 0-2 years 301 (29.3) 145 (35.8) 0.02 1.28 (1.05 to 1.57) 0.02
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score—an indicator of crystallised intelligence, lifetime
intellectual activity, and cultural exposure—is seen to
have a greater impact than educational level, which
was not retained by the initial risk model. This may be
because it is a more accurate assessment of acquired
learning than number of years of formal education in
this generation, of whom many were exposed to war
conditions(secondworldwarandSpanishandAlgerian
civil wars), which interrupted schooling and profes-
sionaltraining.Crystallisedintelligencemaybeconsid-
ered a proxy marker for exposure to intellectual
activity, and determining whether this may have been
confoundedbyassociationwithhigherphysicalactivity
mighthavebeenuseful.Unfortunately,nosimple,inde-
pendent unitary measure of physical activity was avail-
able; however, a recent analysis has shown that the
cognitive component of overall activity rather than the
physical aspect is protective in relation to onset of
dementia.
27TheNealeadultreadingtestscoreisacom-
bination of both genetic ability and cultural exposure,
butthisanalysiscannotdistinguishwhichcomponentis
having the effect of reducing incidence. In the absence
of an answer to this central question, the public health
message can only be to encourage literacy at all ages
irrespective of innate ability.
Eliminating depression and diabetes and increasing
fruit and vegetable consumption were estimated to
lead to an overall 20.7% reduction in incidence of
dementia.Ofthese,depressionmakesthegreatestcon-
tribution; elimination of depression from the elderly
population was estimated to lead to a mean 10.3%
reduction in the number of new cases over seven
years. Our analyses included treatment for depression
and diabetes. The underlying assumption was that
although treatment may have eliminated symptoms
and reduced risk through decreasing length of expo-
sure, the person has nevertheless been exposed to all
the underlying negative biological effects associated
with the disease state that may be linked to the aetiol-
ogy of dementia, such as inflammation, increased per-
meability of the blood-brain barrier, damage to white
matter, and raised cortisol concentrations. In this con-
text, the corollary of our population attributable frac-
tion analyses in terms of public health interventions is
that these disorders should not so much be treated as
prevented from occurring at all. This would imply
targeting and monitoring of people at high risk and
introducing preventive treatment where feasible.
However, the causal relation between depression
and dementia remains unclear. Depression may be a
prodromal sign of dementia, such that its treatment
evenatanearlystagemaynotpreventonsetofdemen-
tia, although previous research has suggested that its
elimination can at least slow the rate of functional
loss.
45 Alternatively, depression may be an indepen-
dent contributor to risk through, for example, inflam-
matory processes or hippocampal damage via a
glucocorticoid cascade, such that treatment may
delay onset. Meta-analyses have failed to adequately
resolve this question,
17 and an intervention pro-
gramme aiming at preventing prolonged exposure to
depression by early treatment (especially in family
members of people with dementia) would greatly
increase our current knowledge of this association.
Comparison with other studies
Recent papers reviewing promising strategies for pre-
vention of dementia have underlined the importance
ofcontrollingvascularriskfactors,mentalactivity,and
depression, but have not been able to prioritise inter-
ventions or take into account exposure rates.
4647 Clin-
ical researchin recent years has focused principallyon
hypertensionasaninterventionmeasure;however,the
HYVET-COG randomised controlled trial of preven-
tion of hypertension actually found a lower two year
incidenceofdementiaintheplacebogroup.
48Ourana-
lyses also suggest significant benefit not from elimina-
tionofhypertensionalonebutratheritsassociatedrisk
factordiabetes.TherecentstudyofLietalfurthersup-
ports this finding, reporting significant reductions in
the incidence of dementia among users of angiotensin
receptor blockers,
49 which offer increased protection
against diabetes and stroke compared with other anti-
hypertensive agents. However, given that the follow-
up period in our study is shorter than that of some
previous studies of hypertension, we may have under-
estimated the importance of this factor.
Potential for intervention
The general conclusion from our population attributa-
ble fraction analyses is that,in the continuedabsenceof
an effective treatment for the dementias, public health
programmes should aim above all at prevention of dia-
betes, which is a well established risk factor for demen-
tia, is unlikely to be simply a dementia prodrome, is
highly prevalent, and is treatable. The high prevalence
of this disorder in the elderly population means that
intervention is likely to have a high impact and be cost
effective, even though the relative risk is modest.
Although increased fruit and vegetable consumption
and crystallised intelligence also have high potential
impact, their relation to dementia, and the intervening
role of lifestyle factors, makes it difficult to formulate
strategies for health intervention at a population level.
Depression is also common, is relatively easy to treat,
andfrequentlyprecedesonsetofdementia;however,its
status as a risk factor rather than (or as well as) an early
Table 2 |Multivariate Cox model and adjusted population attributable fraction (PAF) for seven
year incident mild cognitive impairment or dementia (n=1433, No of events=405)
Risk factor
Cox model*
% PAF (95% CI†)
Cumulative % PAF
(95% CI†) Hazardratio(95%CI) P value
Neale adult reading test <20 1.72 (1.41 to 2.09) <0.001 18.1 (10.9 to 25.4) 18.1 (10.9 to 25.4)
Diabetes 1.85 (1.34 to 2.56) <0.002 4.9 (1.9 to 8.0)
20.7 (11.2 to 29.8) Depression 1.39 (1.13 to 1.71) 0.002 10.3 (3.7 to 17.2)
Fruit/vegetables <twice/day 1.26 (1.02 to 1.56) 0.04 6.5 (0.2 to 13.1)
ApoE4 ε4 allele 1.47 (1.16 to 1.86) 0.001 7.1 (2.4 to 12.0) 7.1 (2.4 to 12.0)
*Including age and sex.
†Bootstrap method.
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ofdepressionare,however,relativelyeasytoscreenata
population level and should be treated whether or not
they are a prodromal feature of dementia; this will in
any case diminish the rate of functional loss.
The most reasonable way forward, taking into
account the above considerations, would be the con-
structionofaninterventionprogrammewithinthegen-
eral population aimed at early screening for glucose
tolerance and insulin resistance and early treatment
of raised depressive symptoms. These risk factors
have been highlighted by previous epidemiological
research, but this is the first study of comparative ben-
efit, estimating the relative advantages of elimination
ofvariousriskfactors.Thesefactorsarenotnecessarily
the most important in terms of disease causality, but
rather those whose elimination, by virtue of their fre-
quency as well as their risk level, is likely to have the
greatestimpactinreducingthenumberoffuturecases.
This leads to the final question of the age at which
suchinterventionsshouldbemade.Giventhatpreven-
tion rather than treatment of these chronic states is to
bethefocusofintervention,thiswouldimplytargeting
a younger age group. Empirical evidence would seem
to support this; for example, dementia is linked to dia-
betes and early changes in cerebrovascular vessels in
mid-life.
5051 A great limitation of current epidemiolo-
gical and clinical research on dementia has been its
focus on cohorts over the age of 65, so that reliably
estimating the extent of exposure to subclinical states
before the onset of disorders such as depression and
diabetes or determining the age at which intervention
and prevention are most likely to be maximally effec-
tive has been impossible. Does controlling insulin
resistance or eliminating depression have the same
impact on incidence if it is carried out at 40 and
70 years?
Strengths and limitations
The main strength of our analyses is the use of a pro-
spectivedatabasewithdiagnosesofdementiavalidated
by neurologists, and not just according to a diagnostic
algorithm,andalsotheinclusionofmeasuresofalmost
all known modifiable risk factors. To our knowledge,
this is the first attempt to model the effects of a theore-
tical population-wide prevention strategy which com-
pares the relative effect of the removal of significant
exposures.
Thestudyis,however,opentoseveralcriticisms.We
havemade many decisions aboutlevelof exposure (for
example biological thresholds and duration of symp-
toms), which may influence both hazard ratios and
population attributable fraction calculations. Dimen-
sionalvariableshavebeentreatedasbinary,asrequired
for population attributable fraction calculations, thus
precluding the formulation of more precise clinical
directives at an individual level but facilitating compar-
isonsacrosscohorts.Although the calculationofpoten-
tial impact fractions would have permitted the use of
multiple categories and not just binary high and low
exposure with these variables,
52 the method assumes
linearity, which we observed to not be the case. The
use of potential impact fractions is also not considered
appropriate when empirical data are available.
Although our model has examined individual risk
factors while adjusting for all the others, we do not
know,forexample,towhatextenttheyareinter-depen-
dent in the real world such that totally eliminating one
mightmodulatetheappearanceofothersowingtoother
factorsnotaccountedforhere.Ourfindingsshouldthus
be validated in other datasets, using alternative defini-
tions of exposure, before the construction of a public
health intervention programme is considered. We
have also made a decision to include mild cognitive
impairmentwithdementia,althoughsomeofthesepeo-
ple may not ever develop dementia. This seemed pre-
ferabletoclassifyingthemwiththe participantswithout
dementia, given the very high risk of dementia in this
group;retrospectively,thisseemstohavebeentheright
decisiongiventhatonly7.6%ofparticipantswhodevel-
oped full dementia in our study did not pass through a
phaseofmildcognitiveimpairment,thusconfirmingits
status as a prodrome.
Our principalaimhasbeentoshowthatthe applica-
tionofpopulationattributablefractionstoepidemiolo-
gical studies of dementia may provide more
meaningful directions for future public health initia-
tives than are currently used. However, the effective-
nessofneutralisingriskfactorsrestsontheextentofthe
causal relation between the risk factor and onset of
dementia. The risk factors included in this study have
all been associated with credible underlying causative
hypotheses, and confounding has been taken into
account for a large number of factors, but the effect of
their elimination cannot be precisely estimated in the
absence of this information.
Conclusions and policy implications
Theestimationofmeanpercentagepopulationattribu-
table fractions from a longitudinal study of risk factors
fordementiasuggeststhatreductionintheincidenceof
dementia over the next seven years would be maxi-
mised by the elimination of diabetes and possibly
also depression (on the assumption that causality can
be established such that it is clearly shown to be a risk
factor and not just a disease prodrome). Increasing
crystallised intelligence and consumption of fruit and
vegetables also seem to have a potentially high impact
at a population level but are difficult to implement as
health prevention targets, as we cannot determine at
which level of exposure they provide protective
effects, and their relation to dementia is not easily dif-
ferentiated from those of other lifestyle factors. Dia-
betes, or perhaps more specifically insulin resistance,
stands for the moment as the primary target given that
causalityhasbeenmoreclearlyestablishedthanforthe
other factors highlighted in this analysis. Population
attributable fraction calculations can provide only a
crude estimate of impact on incidence, but they make
a significant statement about public health priorities in
disease prevention in the face of current knowledge.
Epidemiological intervention studies in cohorts
RESEARCH
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impact of intervention measures.
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